American Statistical Association
Medication and cognitive behavioral treatment are the best-established treatments for social anxiety disorder, yet many individuals remain symptomatic after treatment. The objective is to determine whether combined medication and cognitive behavioral treatment is superior to monotherapy or pill placebo using a randomized, double-blind, placebo-controlled trial. Linear mixed-effects models showed a specific order of effects, with steepest reductions in Liebowitz Social Anxiety Scale scores for the combined group, followed by the monotherapies, and the least reduction in the placebo group. Combined phenelzine and CBGT treatment is superior to either treatment alone and to placebo on dimensional measures and on rates of response and remission.
Carlos Blanco, M.D., Ph.D., M.S. is Professor of Clinical Psychiatry at Columbia University. He obtained his M.D., and Ph.D. degrees at University Autónoma de Madrid, in Spain. He completed his psychiatry residency at Columbia University/NYSPI, where he also earned an M.S. in Biostatistics. His area of interest is the etiology and treatment of mood, anxiety and addictive disorders.
|Date:||Tuesday, April 12, 2011|
|Time:||3:30 - 4:30 P.M.|
New York State Psychiatric Institute
1051 Riverside Drive
6th Floor Multipurpose Room (6602)
New York, New York